Manuele Gori

Dr. Manuele Gori

Institute of Biochemistry and Cell Biology, National Research Council, Monterotondo, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGManuele Gori
Manuele Gori
MSMaria Chiara Simonelli
Maria Chiara Simonelli
SGSara Maria Giannitelli
Sara Maria Giannitelli
LBLuca Businaro
Luca Businaro
MTMarcella Trombetta
Marcella Trombetta
Alberto RainerAlberto Rainer
Alberto Rainer
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease worldwide, ranging from simple steatosis to nonalcoholic steatohepatitis, which may progress to cirrhosis, eventually leading to hepatocellular carcinoma (HCC). HCC ranks as the third highest cause of cancer-related death globally, requiring an early diagnosis of NAFLD as a potential risk factor. However, the molecular mechanisms underlying NAFLD are still under investigation. So far, many in vitro studies on NAFLD have been hampered by the limitations of 2D culture systems, in which cells rapidly lose tissue-specific functions. The present liver-on-a-chip approach aims at filling the gap between conventional in vitro models, often scarcely predictive of in vivo conditions, and animal models, potentially biased by their xenogeneic nature. HepG2 cells were cultured into a microfluidically perfused device under free fatty acid (FFA) supplementation, namely palmitic and oleic acid, for 24h and 48h. The device mimicked the endothelial-parenchymal interface of a liver sinusoid, allowing the diffusion of nutrients and removal of waste products similar to the hepatic microvasculature. Assessment of intracellular lipid accumulation, cell viability/cytotoxicity and oxidative stress due to the FFA overload, was performed by high-content analysis methodologies using fluorescence-based functional probes. The chip enables gradual and lower intracellular lipid accumulation, higher hepatic cell viability and minimal oxidative stress in microfluidic dynamic vs. 2D static cultures, thus mimicking the chronic condition of steatosis observed in vivo more closely. Overall, the liver-on-a-chip system provides a suitable culture microenvironment, representing a more reliable model compared to 2D cultures for investigating NAFLD pathogenesis. Hence, our system is amongst the first in vitro models of human NAFLD developed within a microfluidic device in a sinusoid-like fashion, endowing a more permissive tissue-like microenvironment for long-term culture of hepatic cells than conventional 2D static cultures.

1 July 2013 in Stem Cells
Verified
Journal Article
Open access
PDF file
Federica CampoloFederica Campolo
Federica Campolo
MGManuele Gori
Manuele Gori
RFRebecca Favaro
Rebecca Favaro
SNSilvia Nicolis
Silvia Nicolis
manuela pellegrinimanuela pellegrini
manuela pellegrini
SDSusanna Dolci
Susanna Dolci
Sox2 is a pluripotency-conferring gene expressed in primordial germ cells (PGCs) and postnatal oocytes, but the role it plays during germ cell development and early embryogenesis is unknown. Since Sox2 ablation causes early embryonic lethality shortly after blastocyst implantation, we generated mice bearing Sox2-conditional deletion in germ cells at different stages of their development through the Cre/loxP recombination system. Embryos lacking Sox2 in PGCs show a dramatic decrease of germ cell numbers at the time of their specification. At later stages, we found that Sox2 is strictly required for PGC proliferation. On the contrary, Sox2 deletion in meiotic oocytes does not impair postnatal oogenesis and early embryogenesis, indicating that it is not essential for oocyte maturation or for zygotic development. We also show that Sox2 regulates Kit expression in PGCs and binds to discrete transcriptional regulatory sequences of this gene, which is known to be important for PGCs survival and proliferation. Sox2 also stimulates the expression of Zfp148, which is required for normal development of fetal germ cells, and Rif1, a potential regulator of PGC pluripotency.

15 December 2008 in Cell Cycle
Verified
Journal Article
Closed access
manuela pellegrinimanuela pellegrini
manuela pellegrini
DFDoria Filipponi
Doria Filipponi
MGManuele Gori
Manuele Gori
FBFlorencia Barrios
Florencia Barrios
FLFrancesca Lolicato
Francesca Lolicato
SDSusanna Dolci
Susanna Dolci
While it is known that retinoic acid (RA) induces meiosis in mouse female fetal gonads, the mechanisms which regulate this process during spermatogenesis are poorly understood. We show that the All trans RA derivative (ATRA) and Kit Ligand (KL) increase meiotic entry of postnatal mouse spermatogonia in vitro without synergism. Competence to enter meiosis is reached by spermatogonia only at the stage in which they undergo Kit-dependent divisions. Besides increasing Kit expression in spermatogonia, ATRA also upregulates KL expression in Sertoli cells. Both ATRA and KL increase the expression of Stimulated by Retinoic Acid Gene 8 and Dmc1, an early meiotic marker. A specific Kit tyrosine kinase inhibitor prevents the increase in the number of meiotic cells induced by both the two factors, suggesting that they converge on common Kit-dependent signalling pathways. Meiotic entry induced by ATRA and KL is independent from their ability to affect germ cell viability, and is mediated by the activation of PI3K and MAPK pathways through Kit autophosphorylation. ATRA-induced phosphorylation of the two downstream kinases is mediated by a non-genomic mechanism. These data suggest that RA may control the timing of meiosis by influencing both the somatic and the germ cell compartment of the postnatal testis through the activation of the KL/Kit system.

15 June 2017 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
PMPamela Mozetic
Pamela Mozetic
SGSara Maria Giannitelli
Sara Maria Giannitelli
MGManuele Gori
Manuele Gori
MTMarcella Trombetta
Marcella Trombetta
Alberto RainerAlberto Rainer
Alberto Rainer

15 November 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
Francesco BasoliFrancesco Basoli
Francesco Basoli
SGSara Maria Giannitelli
Sara Maria Giannitelli
MGManuele Gori
Manuele Gori
PMPamela Mozetic
Pamela Mozetic
ABAlessandra Bonfanti
Alessandra Bonfanti
Alberto RainerAlberto Rainer
Alberto Rainer
The rapidly growing field of mechanobiology demands for robust and reproducible characterization of cell mechanical properties. Recent achievements in understanding the mechanical regulation of cell fate largely rely on technological platforms capable of probing the mechanical response of living cells and their physico–chemical interaction with the microenvironment. Besides the established family of atomic force microscopy (AFM) based methods, other approaches include optical, magnetic, and acoustic tweezers, as well as sensing substrates that take advantage of biomaterials chemistry and microfabrication techniques. In this review, we introduce the available methods with an emphasis on the most recent advances, and we discuss the challenges associated with their implementation.

Verified
Journal Article
Open access
PDF file
MAMario Arciello
Mario Arciello
MGManuele Gori
Manuele Gori
RMRoberta Maggio
Roberta Maggio
BBBarbara Barbaro
Barbara Barbaro
MTMirko Tarocchi
Mirko Tarocchi
Clara BalsanoClara Balsano
Clara Balsano
The liver is crucial for human life, and the health of this organ often mirrors the health of the individual. The liver can be the target of several diseases, the most prevalent of which, as a consequence of development and changes in human lifestyles, is the nonalcoholic fatty liver disease (NAFLD). NAFLD is a multifactorial disease that embraces many histo-pathologic conditions and is highly linked to metabolic derangements. Technological progress and industrialization have also had the consequence of releasing pollutants in the environment, for instance pesticides or solvents, as well as by-products of discharge, such as the particulate matter. In the last decade, a growing body of evidence has emerged, shedding light on the potential impact of environmental pollutants on liver health and, in particular, on NAFLD occurrence. These contaminants have a great steatogenic potential and need to be considered as tangible NAFLD risk factors. There is an urgent need for a deeper comprehension of their molecular mechanisms of action, as well as for new lines of intervention to reduce their worldwide diffusion. This review wishes to sensitize the community to the effects of several environmental pollutants on liver health.